Literature DB >> 21329690

TSC1/TSC2 signaling in the CNS.

Juliette M Han1, Mustafa Sahin.   

Abstract

Over the past several years, the study of a hereditary tumor syndrome, tuberous sclerosis complex (TSC), has shed light on the regulation of cellular proliferation and growth. TSC is an autosomal dominant disorder that is due to inactivating mutations in TSC1 or TSC2 and characterized by benign tumors (hamartomas) involving multiple organ systems. The TSC1/2 complex has been found to play a crucial role in an evolutionarily-conserved signaling pathway that regulates cell growth: the mTORC1 pathway. This pathway promotes anabolic processes and inhibits catabolic processes in response to extracellular and intracellular factors. Findings in cancer biology have reinforced the critical role for TSC1/2 in cell growth and proliferation. In contrast to cancer cells, in the CNS, the TSC1/2 complex not only regulates cell growth/proliferation, but also orchestrates an intricate and finely tuned system that has distinctive roles under different conditions, depending on cell type, stage of development, and subcellular localization. Overall, TSC1/2 signaling in the CNS, via its multi-faceted roles, contributes to proper neural connectivity. Here, we will review the TSC signaling in the CNS.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21329690      PMCID: PMC3070766          DOI: 10.1016/j.febslet.2011.02.001

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  120 in total

1.  Phosphorylation and binding partner analysis of the TSC1-TSC2 complex.

Authors:  Mark Nellist; Peter C Burgers; Ans M W van den Ouweland; Dicky J J Halley; Theo M Luider
Journal:  Biochem Biophys Res Commun       Date:  2005-08-05       Impact factor: 3.575

2.  Neurotrophin regulation of cortical dendritic growth requires activity.

Authors:  A K McAllister; L C Katz; D C Lo
Journal:  Neuron       Date:  1996-12       Impact factor: 17.173

3.  Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations.

Authors:  M G Butler; M J Dasouki; X-P Zhou; Z Talebizadeh; M Brown; T N Takahashi; J H Miles; C H Wang; R Stratton; R Pilarski; C Eng
Journal:  J Med Genet       Date:  2005-04       Impact factor: 6.318

4.  The NF1 tumor suppressor critically regulates TSC2 and mTOR.

Authors:  Cory M Johannessen; Elizabeth E Reczek; Marianne F James; Hilde Brems; Eric Legius; Karen Cichowski
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-03       Impact factor: 11.205

5.  Inhibition of Src-like kinases reveals Akt-dependent and -independent pathways in insulin-like growth factor I-mediated oligodendrocyte progenitor survival.

Authors:  Qiao-Ling Cui; Wen-Hua Zheng; Remi Quirion; Guillermina Almazan
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

Review 6.  Brain abnormalities in tuberous sclerosis complex.

Authors:  Francis J DiMario
Journal:  J Child Neurol       Date:  2004-09       Impact factor: 1.987

7.  Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration.

Authors:  Poonam Verma; Sabrina Chierzi; Amanda M Codd; Douglas S Campbell; Ronald L Meyer; Christine E Holt; James W Fawcett
Journal:  J Neurosci       Date:  2005-01-12       Impact factor: 6.167

8.  Local translation of RhoA regulates growth cone collapse.

Authors:  Karen Y Wu; Ulrich Hengst; Llewellyn J Cox; Evan Z Macosko; Andreas Jeromin; Erica R Urquhart; Samie R Jaffrey
Journal:  Nature       Date:  2005-08-18       Impact factor: 49.962

9.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.

Authors:  A Pause; G J Belsham; A C Gingras; O Donzé; T A Lin; J C Lawrence; N Sonenberg
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

10.  Glycogen synthase kinase-3beta phosphorylation of MAP1B at Ser1260 and Thr1265 is spatially restricted to growing axons.

Authors:  Niraj Trivedi; Phil Marsh; Robert G Goold; Alison Wood-Kaczmar; Phillip R Gordon-Weeks
Journal:  J Cell Sci       Date:  2005-03-01       Impact factor: 5.285

View more
  50 in total

1.  CB2 cannabinoid receptors promote neural progenitor cell proliferation via mTORC1 signaling.

Authors:  Javier Palazuelos; Zaira Ortega; Javier Díaz-Alonso; Manuel Guzmán; Ismael Galve-Roperh
Journal:  J Biol Chem       Date:  2011-11-18       Impact factor: 5.157

Review 2.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

Review 3.  TSC1 R509X Mutation in a Chinese Family with Tuberous Sclerosis Complex.

Authors:  Yu Zhang; Jing Gan; Zheng Pu; Ming ming Xu; Li feng Wang; Yu hua Li; Zhen guo Liu
Journal:  Neuromolecular Med       Date:  2015-04-22       Impact factor: 3.843

4.  Longitudinal changes in diffusion properties in white matter pathways of children with tuberous sclerosis complex.

Authors:  Fiona M Baumer; Jae W Song; Paul D Mitchell; Rudolph Pienaar; Mustafa Sahin; P Ellen Grant; Emi Takahashi
Journal:  Pediatr Neurol       Date:  2015-02-16       Impact factor: 3.372

5.  Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.

Authors:  Delia M Talos; Hongyu Sun; Bela Kosaras; Annelise Joseph; Rebecca D Folkerth; Annapurna Poduri; Joseph R Madsen; Peter M Black; Frances E Jensen
Journal:  Ann Neurol       Date:  2012-03-23       Impact factor: 10.422

6.  Before epilepsy unfolds: finding the epileptogenesis switch.

Authors:  Annamaria Vezzani
Journal:  Nat Med       Date:  2012-11       Impact factor: 53.440

Review 7.  Potential for treatment of severe autism in tuberous sclerosis complex.

Authors:  Tanjala T Gipson; Gwendolyn Gerner; Mary Ann Wilson; Mary E Blue; Michael V Johnston
Journal:  World J Clin Pediatr       Date:  2013-08-08

8.  A novel TSC2 mutation in a Chinese family with tuberous sclerosis complex.

Authors:  Zheng Yu; Xin Zhang; Hong Guo; Yun Bai
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

9.  A mouse model of DEPDC5-related epilepsy: Neuronal loss of Depdc5 causes dysplastic and ectopic neurons, increased mTOR signaling, and seizure susceptibility.

Authors:  Christopher J Yuskaitis; Brandon M Jones; Rachel L Wolfson; Chloe E Super; Sameer C Dhamne; Alexander Rotenberg; David M Sabatini; Mustafa Sahin; Annapurna Poduri
Journal:  Neurobiol Dis       Date:  2017-12-20       Impact factor: 5.996

Review 10.  Activity-dependent neuronal signalling and autism spectrum disorder.

Authors:  Daniel H Ebert; Michael E Greenberg
Journal:  Nature       Date:  2013-01-17       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.